• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Liver Cancer UK HomepageLiver Cancer UK

Part of the British Liver Trust

  • About us
  • Health professionals
  • Talk to a nurse 0800 652 7330
  • Twitter
  • Liver cancer information
    • Types of liver cancer
      • HCC liver cancer
        • Overview
        • What is HCC?
        • Symptoms
        • Risks and causes
        • Diagnosis
          • Tests
          • Questions for your doctor
        • Treatment
          • Stages
          • Early stage HCC (0-A)
          • Intermediate HCC (stage B)
          • Advanced HCC (stage C)
          • Very advanced (stage D)
          • If your HCC comes back (recurrence)
          • Check-ups
          • Outcomes (prognosis)
        • Living with HCC
      • Bile duct cancer
        • Overview
        • What is bile duct cancer?
        • Symptoms
        • Risks and causes
        • Diagnosis
          • Tests
          • Questions for your doctor
        • Treatment
          • Stages
          • If cancer can be removed
          • If cancer can’t be removed
          • If cancer is advanced or has come back
          • Questions for your doctor
          • Check-ups
          • Outcomes (prognosis)
        • Living with bile duct cancer
      • Rare types of liver cancers
      • Secondary liver cancer
    • Just diagnosed?
    • Types of treatment
      • Surgery
        • Types of surgery
        • Preparing for surgery
        • After surgery
      • Targeted cancer medicines (biological therapies)
      • Chemotherapy
      • Embolization, TACE and TARE or SIRT
      • Ablation
      • Radiotherapy
      • Treatment for symptoms and advanced cancer
      • About clinical trials
    • Risk and causes of liver cancer
    • Liver cancer tests
    • Living with liver cancer
      • Diet and exercise
      • Coping with advanced cancer
      • Mental wellbeing
      • Money matters
      • Support from others
      • Complementary and alternative therapies
      • Patient stories
    • Our booklets and resources
    • Glossary / useful words
  • Support for you
  • How you can help
  • News and blogs
  • Donate
Home » News and Blogs » British Liver Trusts calls for action on liver…
News

British Liver Trusts calls for action on liver cancer

April 2, 2022

The British Liver Trust submitted a response to the Government’s ambitious 10-Year Cancer Plan, which seeks to make the country’s cancer care system the ‘best in Europe’, last month.

Since the 1990s, liver cancer incidence rates have increased by more than two-and-a-half times in the UK. If the NHS Long Term Plan is to meet its ambitions and commitments to improve cancer outcomes and services in England, over the next ten years, it is vital that we address ‘less survivable cancers’, including liver cancer.

Patients diagnosed with liver cancer have shockingly poor outcomes, with only 13% of people surviving for five years after being diagnosed.

Liver cirrhosis is the major risk factor for liver cancer. One in three people with liver cirrhosis will go on to develop liver cancer yet many people are diagnosed with liver cancer at the same time as their underlying liver condition.

The British Liver Trust submission called for;

  • Improved early detection of liver cirrhosis in populations at risk, as liver disease and cancer is often asymptomatic.
  • Better and more effective surveillance programmes.
  • Research is urgently needed to identify new biomarkers and screening to identify patients most at risk.
  • Improved access to treatments and reducing variation in care across the UK
  • A comprehensive alcohol strategy, including product labelling and Minimum Unit Pricing in England.
  • Improving population health.

The British Liver Trust also submitted a response as a member of the Less Survivable Cancers Taskforce (LSCT).  Together, six of these less survivable cancers lung, pancreatic, liver, brain, oesophageal and stomach are responsible for a half of all deaths from common cancers and make up a quarter of cancer cases. While some cancers have seen remarkable progress, these cancers are as deadly as they were 40 years ago. They account for a quarter of all cancer diagnoses each year in England and because of their poor outcomes, around 40% of cancer deaths.

The Less Survivable Cancers Taskforce submission urged the Government to use this 10-Year Cancer Plan to make specific commitments and targets for the less survivable cancers and drive forward the transformational change we need in diagnosis, treatments and care.

The British Liver Trust was delighted that the Health Select Committee report on Cancer Services, published on 29 March, picked up on our specific calls to action and highlighted the challenges facing people with ‘rare and less common and less survivable cancers’. Our early pressure paid off with the report stating

“There are specific challenges facing people with rare and less common and less survivable cancers, including that they are often harder to diagnose and that issues with spreading best practice for treating less common cancers are more pronounced. Despite some positive changes such as Rapid Diagnostic Centres, it is not clear that sufficient focus is being given to rare and less common and less survivable cancers. The Government must consider rare, less common and less survivable cancers specifically as part of its new cancer plan. NHS England should also produce an action plan for rare, less common and less survivable cancers, containing clear commitments to address key issues around the diagnosis and treatment of those cancers. It should cover raising awareness of these cancers among health professionals and the delivery of optimal treatments.”

The British Liver Trust also joined over 50 other charities as part of One Cancer Voice, in its response to the consultation. The submission can be read here.

Responding to the Government’s 10-Year Cancer Plan, British Liver Trust Chief Executive, Pamela Healy OBE said:

“Now more than ever, the government must ensure people most at risk of liver cancer are not overlooked and left behind. We are calling for a step change in early detection and surveillance of liver cancer to make a meaningful impact on 5-year survival rates.”

More news items
« British Liver Trust joins over 50 cancer charities to call on the Government to ensure better cancer care
One Cancer Voice calls on Sajid Javid to ensure the 10-Year Cancer Plan delivers the best cancer care system in Europe »

Footer

Liver Cancer UK logo
British Liver Trust logo

Quick links


  • Just been diagnosed
  • Living with cancer
  • Hepatocellular carcinoma (HCC)
  • Bile duct cancer

Contact us


Talk to a nurse on our helpline

0800 652 7330

General enquiries:

info@britishlivertrust.org.uk

01425 481 320

© British Liver Trust. All rights reserved. Registered Office: Venta Court, 20 Jewry Street, Winchester, SO23 8FE.
Registered Charity England and Wales 298858, Scotland SC042140. Company Limited by Guarantee Registered in England and Wales, Company No 2227706

Privacy policy | Cookies

Talk to a nurse on our helpline

0800 652 7330

Scroll Up